BusinessTimes.top
BusinessTimes is for folks who likes to get updated before others about latest news of Stock Markets, Business News, Personal Funds, Currencies and Much More. If you have any kind of questions, please feel free to ask by contacting us.

Arvinas Reports Q4 and Full Year 2019 Financial Results

Arvinas reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update.

Arvinas (NASDAQ:ARVN) reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update.

As quoted in the press release:

“2019 was an exciting year for Arvinas, marked by tremendous clinical and corporate progress. We were delighted to present the first human clinical data from targeted protein degraders along with preclinical data demonstrating the brain-penetrating potential of our PROTAC® protein degraders. These data underscore the potential of our platform to create safe and well-tolerated drugs for the treatment of a variety of life-threatening diseases,” said John Houston, Ph.D., Chief Executive Officer of Arvinas.

Click here to read the full press release.

biotech investing start here report

Is the biotech market the perfect mesh between the technology and pharmaceutical market?

 

Read our FREE outlook report below!

 

You might also like

Comments are closed.